Pharma Tips

What is FDA's Orange Book

By: Pharma News | Views: 2911 | Date: 06-Jun-2014

“The Orange Book" is actually the U.S. Food and Drug Administration's (FDA) official listing of Approved Drug Products with Therapeutic Equivalences. “Orange book” is published by the FDA's Centre for Drug Evaluation and Research (CDER).The List contains therapeutic equivalence evaluations for approved multisource prescription drug products. Generic drug evaluations contained in the list are designed to serve as public education and advice to physicians, pharmacists and state health agencies, and to help p



What is FDA's Orange Book (Approved Drug Products With Therapeutic Equivalence Equations)

FDA's Orange Book

 
 
FDA ORANGE BOOK
(Approved Drug Products with Therapeutic Equivalence Evaluations)
 

 
“The Orange Book" is actually the U.S. Food and Drug Administration's (FDA) official listing of Approved Drug Products with Therapeutic Equivalences. 

 
“Orange book” is published by the FDA's Centre for Drug Evaluation and Research (CDER).The List contains therapeutic equivalence evaluations for approved multisource prescription drug products. Generic drug evaluations contained in the list are designed to serve as public education and advice to physicians, pharmacists and state health agencies, and to help promote access to lower priced medicines.
 
The Orange Book is divided into four parts: Part one includes approved prescription drug products with therapeutic equivalence evaluations. Part two lists approved over-the-counter (OTC) drug products for those drugs that may not be marketed without NDAs or ANDAs because they are not covered under existing OTC monographs. Part three includes drug products administered by the Center for Biologics Evaluation and Research. Part four includes a list of approved products that have never been marketed, are for export only, are intended for military use, have been discontinued from marketing, or have had their approvals withdrawn for reasons other than safety or efficacy.
 
The therapeutic equivalence evaluations contained in the list refer to the FDA's criteria for approved multi-source prescription drug products. The evaluations are presented in code letters corresponding to the type of evaluation used. An explanation of the code appears in the introduction to the list. The main criteria for the inclusion of a drug product on the list are that the product has received an effective approval that has not been withdrawn for efficacy or safety or efficacy causes. Inclusion of products on the list is independent of any current regulatory action through administrative or judicial means against a drug product.

Previous Page Next Page

People Searching On This Page:
  • in oragange drug products divided in which part
  • fda orange book

Related Pages


Difference Between Orange & Lemon Trees

Difference Between Orange & Lemon Trees

Articles | Pharmacognosy | Herbal Drug
Date:
12-Jun-2014  Views: 1849

The image of a citrus tree with brightly colored fruits nestled amid its dark green leaves calls to mind sunshine and balmy subtropical breezes. Both ...
Oranges : Pharmacognosy & Medicinal Uses

Oranges : Pharmacognosy & Medicinal Uses

Articles | Pharmacognosy
Date:
09-Sep-2013  Views: 1721

Oranges contain Vitamin B6, otherwise called “mood vitamin” as B6 acts in the brain to help produce serotonin and thus make us happier ...
List of Pharmaceutical Quality Assurance Books

List of Pharmaceutical Quality Assurance Books

Articles | Quality Assurance
Date:
13-Jul-2013  Views: 3516

New Books on Pharmaceutical Quality Assurance ...
Pharma Social Networking Benefits - Facebook, Twitter & more

Pharma Social Networking Benefits - Facebook, Twitter & more

Articles
Date:
27-Apr-2013  Views: 6399

Facebook, Twitter and more have led us to social media mayhem! Pharma companies are no exception, with many companies having a web presence through so ...
List of Regulatory Affairs Books & E-Books

List of Regulatory Affairs Books & E-Books

Articles | Regulatory Affair
Date:
26-Feb-2013  Views: 12160

This book is a roadmap to the U.S. Food and Drug Administration and drug, biologic, and medical device development. It is written in plain English, wi ...
Post Your Comments (No Login Require)
Name : (required)
Email : (required)
Website :

Comment : (required)

46  + 6 =     
Comments
People Searched About:
In Oragange Drug Products Divided In Which Part   |   Fda Orange Book   |  
Google : 412 times | Yahoo : 72 times | Yahoo : 72 times | Bing : 19 times |